Ethics & Informed Consent: Randomised Controlled Trial (RCT) (Argentina)

1. Ethical Principles & Legislative Framework

In research involving human participants, securing ethical clearance is a critical first step. For a Randomised Controlled Trial (RCT) being conducted in Argentina, study designs must align with the primary regulatory legislation: ANMAT Provision 6677/10 & National Registry of Health Research (RENIS). This statutory framework ensures participant welfare, confidentiality, and voluntary involvement are protected.

Administrative review and formal approval are managed by a local or regional Comité de Ética en Investigación. Researchers must secure full approval or a formal exemption certificate from this board before recruiting any participants or commencing data collection.

2. Study Design Elements & Reporting Integrity

For a Randomised Controlled Trial (RCT), the review board places significant focus on methodological transparency. The application must outline the research rationale, recruitment protocols, inclusion and exclusion criteria, and data protection measures.

Study Classification: High Risk (Interventional)

RCTs are interventional, requiring robust safety oversight, clear drug/device allocation concealment protocols, and detailed descriptions of emergency unblinding procedures.

To guarantee academic integrity and reproducibility, the study report and subsequent publications should follow the internationally recognised reporting standard: CONSORT statement.

3. Informed Consent & Information Sheet Guidelines

A robust participant information sheet and informed consent form are critical parts of the ethical application. Ensure your documentation incorporates the following components:

• Plain Language Explanations: Avoid complex medical or technical terminology. Ensure readability matches the general population.
• Voluntary Participation: Explicitly state that participation is entirely voluntary and that individuals can withdraw at any time without negative consequences.
• Confidentiality & Data Controls: Explain how participant data will be anonymised or pseudonymised, who will have access to it, and how long it will be securely retained under Personal Data Protection Act No. 25,326 (LPDP).
• Risk/Benefit Disclosure: Clearly list any potential risks, discomforts, or direct benefits associated with participation in the study.
• Ethics Board Contact Information: Provide the contact details of the reviewing Comité de Ética en Investigación so participants can reach out if they have questions or concerns.

Research Ethics, Clinical Trials & Institutional Governance

Ensuring safety in this Randomised Controlled Trial (RCT) in Argentina demands prioritizing beneficence in research ethics above all other design criteria. The oversight committee reviews trials to prevent historical clinical abuses and ensure that vulnerable populations research ethics are fully respected. To satisfy requirements, investigators must provide a compliant informed consent template research form to all prospective participants. Securing institutional review board approval from the local Comité de Ética en Investigación is a strict requirement before patient enrollment. Aligning animal protocols with the animal research ethics 3rs is a key step to secure final research ethics approval. All records and signed consent sheets must reside on secure local servers in Argentina to protect patient privacy and comply with national guidelines.

4. Regulatory Checklist Table

To streamline your ethical review submission, use the structured alignment checklist below:

6. Frequently Asked Questions